May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Elizabeth McKenna: PGV001 in Patients with Solid and Hematological Malignancies
Mar 24, 2025, 13:36

Elizabeth McKenna: PGV001 in Patients with Solid and Hematological Malignancies

Elizabeth McKenna, Executive Director of Cancer Discovery at the American Association for Cancer Research, shared an article by Mansi Saxena, et al. on X:

Now in Cancer Discovery:

PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform:

Phase I Study in Patients with Solid & Hematological Malignancies in the Adjuvant Setting – by Mansi Saxena, Tom Marron, Philip Friedlander, Alex rubinsteyn, Bhardwaj Lab, et al.”

Elizabeth McKenna: PGV001 in Patients with Solid and Hematological Malignancies

PGV001, a multi-peptide personalized neoantigen vaccine platform: Phase I study in patients with solid and hematological malignancies in the adjuvant setting.

Authors: Mansi Saxena, et al.

Elizabeth McKenna: PGV001 in Patients with Solid and Hematological Malignancies